期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

中国早期乳腺癌卵巢功能抑制临床应用专家共识(2016年版) 被引量：26

Expert consensus on clinical applications of ovarian function suppression for Chinese women with early breast cancer 2016
下载PDF
导出
摘要 乳腺癌已经成为威胁中国女性健康的第一大恶性肿瘤，发病率呈逐年递增趋势。中国乳腺癌发病率年增幅速度是世界平均水平的2倍，且年轻化趋势显著，约有60％的患者在诊断时仍为绝经前状态。
作者 徐兵河 邵志敏 胡夕春 江泽飞
机构地区 中国医学科学院肿瘤医院肿瘤内科 复旦大学附属肿瘤医院乳腺外科 复旦大学附属肿瘤医院肿瘤内科 军事医学科学院附属医院乳腺肿瘤科
出处 《中国癌症杂志》 CAS CSCD 北大核心 2016年第8期712-720,共9页 China Oncology
关键词 乳腺癌 卵巢功能抑制 内分泌治疗 Breast cancer Ovarian fimction suppression Endocrine therapy
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献34

  • 1FAN L, STRASSER-WEIPPL K, LI J J, et al. Breast cancer in China [J]. Lancet Oncol, 2014, 15(7): e279-289.
  • 2Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials [ J ] . Lancet, 2005, 365(9472): 1687-1717.
  • 3DAVIES C, PAN H, GODWIN J, et al. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breastcancer: ATLAS, a randomised trial [ J ] . Lancet, 2013, 381(9869): 805-816.
  • 4GRAY R G, REA D, HANDLEY K, et al. aTTom: long term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6 953 women with early breast cancer [ J ] . J Clin Oncol, 2013, 31(18): 2631-2632.
  • 5CUZICK J, AMBROISINE L, DAVIDSON N, et al. Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor- positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials [ J ] . Lancet, 2007, 369(9574): 1711-1723.
  • 6GOEL S, SHARMA R, HAMILTON A, et al. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women [ J ] . Cochrane Database Syst Rev, 2009, 7(4): CD004562.
  • 7FRANCIS P A, REGAN M M, FLEMING G F, et al. Adjuvant ovarian suppression in premenopausal breast cancer [J]. N Engl ] Ned, 2015, 372(5): 436-446.
  • 8PAGANI O, REGAN M M, WALLEY B A, et al. Adjuvant exemestane with ovarian suppression in premenopausal breast cancer [ J ] . N Engl J Med, 2014, 371(2): 107-118.
  • 9HARRISON G S, WIERMAN M E, NETT T M, et al. Gonadotropin-releasing hormone and its receptor in normal and malignant cells [ J ] . Endocr Relat Cancer, 2004, 11(4): 725-748.
  • 10DOISNEAU-SIXOU S F, SERGIO C M, CARROLL J S, et al. Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells [ J ] . Endocr Relat Cancer, 2003, 10(2): 179-186.

二级参考文献48

  • 1沈镇宙,宋三泰,张斌,邵志敏,陆劲松.中国绝经前女性乳腺癌患者辅助治疗后绝经判断标准及芳香化酶临床应用共识(草案修正案)[J].中国癌症杂志,2011,21(5):418-420. 被引量：18
  • 2李惠平,马力文,张淑兰,贾廷珍,邓惠静,张照辉,梁莉,王墨培,肖宇,曹保山,陈森,汪有蕃.绝经前乳腺癌化疗致闭经的观察及临床意义[J].中华肿瘤杂志,2006,28(11):848-851. 被引量：23
  • 3ATAC Trialists' Group. Result of the ATAC (Arimidex, Tamoxifen, alone or in combination) trial after completion of 5 years adjuvant treatment for breast cancer [ J]. Lancet, 2005, 365:60-62.
  • 4Coates AS, Keshaviah A, Thurlimann B, et al. Five years ofletrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98 [ J ]. J Clin Oncol, 2007, 25 (5) : 486-492.
  • 5Milla-Santos A, Milla L, Portella J, et al. Anatrozole versus tamoxifen as first-line therapy in postmenopausal patients with hormone-dependent advanced breast cancer [ J ]. Am J Clin Oncol, 2003, 26:317-322.
  • 6NCCN. Clinical Practice Guidelines in OncologyTM Breast Cancer, ( Version 2) 2008. [2008-09-01 ]. http://www. nccn. org.
  • 7NCCLS. How to define and determine reference intervals in theclinical laboratory ; approved guideline--second edition [ M ]. Wayne : NCCLS ,2000.
  • 8Clinical and Laboratory Standards Institute (CLSI). Defining, establishing, and verifying reference intervals in the clinical laboratory; Approved Guideline-Third Edition [ M ]. Wayne: Clinical and Laboratory Standards Institute, 2000.
  • 9Horn PS, Horowitz GL, Pesce AJ. Lab guidelines & standards [ J]. Labmedicine, 2009, 40 : 75-76.
  • 10Whoon Jong Kil,Seung Do Ahn,Seong Soo Shin,Sang-wook Lee,Eun Kyung Choi,Jong Hoon Kim,Byung Ho Son,Sei-Hyun Ahn,Woo Kun Kim,Sung Bae Kim.Treatment-induced menstrual changes in very young (<35 years old) breast cancer patients[J]. Breast Cancer Research and Treatment . 2006 (3)

共引文献1140

同被引文献178

引证文献26

二级引证文献167

中国癌症杂志
2016年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部